On May 6th, the 7th Future Healthcare 100 Summit, co-organized by Shanghai Zhangjiang Group and VB100, was held. Yinjia (Shanghai) Biomedical Technology Co., Ltd. ("Yinjia Bio") was successfully recognized in the 2023 Future Healthcare 100 Top 100 Innovative Healthcare Business and Supply Chain Services list. This honor acknowledges Yinjia Bio's continuous innovation and alignment with market demands in the biopharmaceutical field.
The Future Healthcare 100 Summit is the largest and most informative industry-capital convergence event in China's healthcare innovation sector. It aims to gather core industry forces, drive innovation in the health and medical industry, and create a platform for communication and collaboration across the entire healthcare industry chain. The Future Healthcare 100 and the Top 100 Innovative Healthcare Business and Supply Chain Services list are selected by authoritative medical industry institutions to recognize companies demonstrating outstanding performance and leadership in the future healthcare field.
Currently, a new round of technological and industrial revolution is accelerating. Breakthroughs in life sciences are flourishing, and the deep integration of the biotech and information industries holds significant importance for global health development and economic recovery.
Receiving this honor demonstrates that Yinjia Bio's performance in technological innovation, product quality, and market presence is highly recognized by the industry and expert judges. As a technology-driven innovation company focused on the broad application of proteins in biopharmaceuticals and other fields, Yinjia Bio aims to provide more solutions for unmet needs in the global life and health industry through our products. Today, with its excellence in quality, technological innovation, and customer service, Yinjia Bio has become one of the most acclaimed innovative companies in China.
Dr. Wu Yifei, Founder and Chairman, stated: "We are very pleased to be included in the Future Healthcare 100 list. This recognizes our team's relentless pursuit of excellence and highlights our important role in the collaborative ecosystem of the biopharmaceutical industry. In the future, we will remain true to our original aspirations, committed to providing more and better products and services for the global life and health industry."
Yinjia Bio will continue to uphold the principles of "Innovation, Quality, Service," constantly improving ourselves to bring more value and possibilities to our customers and the industry. We will strengthen technological innovation and enhance product quality to meet customer and market demands. Simultaneously, we will focus on corporate social responsibility, contributing more to the development of China's health technology and medical industry.
Prev